Login Register Cart 0
Generic placeholder image

Current HIV Research

Editor-in-Chief

ISSN (Print): 1570-162X
ISSN (Online): 1873-4251

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Biography

Meet Our Editorial Board Member

Author(s): Gabriella d’Ettorre

Volume 19, Issue 2, 2021

Published on: 27 January, 2021

Page: [101 - 102] Pages: 2

DOI: 10.2174/1570162X1902210127093321

Next »
[1]
Spagnolello O, Gallagher B, Lone N, Ceccarelli G. The role of targeted hiv screening in the emergency department: A scoping review Curr HIV Res 2020. [Online ahead of print]..
[2]
Ciccullo A, Baldin G, Borghi V, Sterrantino G, Madeddu G, Latini A. Overall tolerability of integrase inhibitors in clinical practice: results from a multicenter italian cohort. AIDS Res Hum Retroviruses 2020; 37(1): 4-10.
[3]
Pinacchio C, Scagnolari C, Iebba V, et al. High abundance of genus Prevotella is associated with dysregulation of IFN-I and T cell response in HIV-1-infected patients. AIDS 2020; 34(10): 1467-73.
[4]
Innocenti GP, Santinelli L, Laghi L, et al. Modulation of Phenylalanine and Tyrosine Metabolism in HIV-1 Infected Patients with Neurocognitive Impairment: Results from a Clinical Trial. Metabolites 2020; 10(7): 274.
[http://dx.doi.org/10.3390/metabo10070274 ] [PMID: 32635406]
[5]
Taramasso L, Fabbiani M, Nozza S, et al. INACTION study group. Predictors of incomplete viral response and virologic failure in patients with acute and early HIV infection. Results of Italian Network of ACuTe HIV InfectiON (INACTION) cohort. HIV Med 2020; 21(8): 523-35.
[http://dx.doi.org/10.1111/hiv.12885 ] [PMID: 32578947]
[6]
Santinelli L, Ceccarelli G, Borrazzo C, et al. Sex-related differences in markers of immune activation in virologically suppressed HIV-infected patients. Biol Sex Differ 2020; 11(1): 23.
[http://dx.doi.org/10.1186/s13293-020-00302-x ] [PMID: 32357901]
[7]
Muscatello A, Nozza S, Fabbiani M, et al. Enhanced Immunological Recovery With Early Start of Antiretroviral Therapy During Acute or Early HIV Infection-Results of Italian Network of ACuTe HIV InfectiON (INACTION) Retrospective Study. Inaction Study Group Pathog Immun 2020; 5(1): 8-33.
[8]
Santinelli L, Ceccarelli G, Borrazzo C, et al. Real word outcomes associated with use of raltegravir in older people living with HIV: results from the 60 months follow-up of the RAL-age cohort. Expert Rev Anti Infect Ther 2020; 18(5): 485-92.
[http://dx.doi.org/10.1080/14787210.2020.1733415 ] [PMID: 32096433]
[9]
Maggiorella MT, Sanarico N, Brindicci G, et al. High HIV-1 diversity in immigrants resident in Italy (2008-2017). Italian Network for HIV Characterization. Sci Rep 2020; 10(1): 3226.
[10]
Montrucchio C, De Nicolò A, D’Ettorre G, et al. Serum Trimethylamine-N-oxide Concentrations in People Living with HIV and the Effect of Probiotic Supplementation. Int J Antimicrob Agents 2020; 55(4)105908
[http://dx.doi.org/10.1016/j.ijantimicag.2020.105908 ] [PMID: 31991223]
[11]
Landi C, Santinelli L, Bianchi L, et al. Cognitive impairment and CSF proteome modification after oral bacteriotherapy in HIV patients. J Neurovirol 2020; 26(1): 95-106.
[http://dx.doi.org/10.1007/s13365-019-00801-7 ] [PMID: 31677067]
[12]
Ceccarelli G, Borrazzo C, Lazzaro A, et al. Diagnostic Issues of Asymptomatic Neurosyphilis in HIV-Positive Patients: A Retrospective Study. Brain Sci 2019; 9(10): 278.
[http://dx.doi.org/10.3390/brainsci9100278 ] [PMID: 31627294]
[13]
Capotosto L, D’Ettorre G, Ajassa C, et al. Assessment of Biventricular Function by Three-Dimensional Speckle Tracking Echocardiography in Adolescents and Young Adults with Human Immunodeficiency Virus Infection: A Pilot Study. Cardiology 2019; 144(3-4): 101-11.
[http://dx.doi.org/10.1159/000503140 ] [PMID: 31614346]
[14]
Mussini C, Roncaglia E, Borghi V, et al. A prospective randomized trial on abacavir/lamivudine plus darunavir/ritonavir or raltegravir in HIV-positive drug-naïve patients with CD4 <200 cells/uL (the PRADAR study). PLoS One 2019; 14(9)e0222650
[15]
Falasca F, Cavallari EN, Innocenti GP, et al. Antiviral Activity of Fecal Water Samples from HIV-1 Infected Subjects Treated with a Specific Probiotic Formulation. Curr HIV Res 2019; 17(3): 183-9.
[http://dx.doi.org/10.2174/1570162X17666190903230622 ] [PMID: 31490760]
[16]
Ceccarelli G, Statzu M, Santinelli L, et al. Challenges in the management of HIV infection: update on the role of probiotic supplementation as a possible complementary therapeutic strategy for cART treated people living with HIV/AIDS. Expert Opin Biol Ther 2019; 19(9): 949-65.
[http://dx.doi.org/10.1080/14712598.2019.1638907 ] [PMID: 31260331]
[17]
Ceccarelli G, Pinacchio C, Santinelli L, et al. Physical Activity and HIV: Effects on Fitness Status, Metabolism, Inflammation and Immune-Activation. AIDS Behav 2020; 24(4): 1042-50.
[http://dx.doi.org/10.1007/s10461-019-02510-y ] [PMID: 31016505]
[18]
Santinelli L, Statzu M, Pierangeli A, et al. Increased expression of IL-32 correlates with IFN-γ, Th1 and Tc1 in virologically suppressed HIV-1-infected patients. Cytokine 2019; 120: 273-81.
[http://dx.doi.org/10.1016/j.cyto.2019.01.012 ] [PMID: 30910260]
[19]
d’Ettorre G, Borrazzo C, Pinacchio C, et al. Increased IL-17 and/or IFN-γ producing T-cell subsets in gut mucosa of long-term-treated HIV-1-infected women. AIDS 2019; 33(4): 627-36.
[http://dx.doi.org/10.1097/QAD.0000000000002122 ] [PMID: 30608274]
[20]
Statzu M, Santinelli L, Viscido A, et al. Increased SAMHD1 transcript expression correlates with interferon-related genes in HIV-1-infected patients. Med Microbiol Immunol (Berl) 2019; 208(5): 679-91.
[http://dx.doi.org/10.1007/s00430-018-0574-x ] [PMID: 30564919]
[21]
Trunfio M, Pinnetti C, Focà E, et al. Cerebrospinal fluid HIV-1 escape according to different thresholds and underlying comorbidities: is it time to assess the definitions? AIDS 2019; 33(4): 759-62.
[http://dx.doi.org/10.1097/QAD.0000000000002091 ] [PMID: 30531317]
[22]
Pinacchio C, Scheri GC, Statzu M, et al. Type I/II Interferon in HIV-1-Infected Patients: Expression in Gut Mucosa and in Peripheral Blood Mononuclear Cells and Its Modification upon Probiotic Supplementation. J Immunol Res 2018; 20181738676
[23]
Ciccullo A, Baldin G, Capetti A, et al. A comparison between two dolutegravir-based two-drug regimens as:switch strategies in a multicentre cohort of HIV-1-infected patients. Antivir Ther 2019; 24(1): 63-7.
[http://dx.doi.org/10.3851/IMP3270 ] [PMID: 30277466]
[24]
Cella E, Foley BT, Riva E, et al. HIV-2 Infection in a Migrant from Gambia: The History of the Disease Combined with Phylogenetic Analysis Revealed the Real Source of Infection. AIDS Res Hum Retroviruses 2018; 34(12): 1090-4.
[http://dx.doi.org/10.1089/aid.2018.0112 ] [PMID: 29954191]
[25]
Pavone P, Alfieri G, Corano-Scheri G, et al. Systemic adipokines, hepatokines and interleukin-6 in HCV-monoinfected and HCV/HIV coinfected patients treated with direct antiviral agents (DAAs). Clin Res Hepatol Gastroenterol 2018; 42(3): e45-8.
[http://dx.doi.org/10.1016/j.clinre.2018.02.004 ] [PMID: 29735250]

Rights & Permissions Print Cite
Article Metrics
22
1
© 2024 Bentham Science Publishers | Privacy Policy